ESI Announces Fourth Quarter and Full Year Fiscal 2018 Results
May 08, 2018 20:06 pm UTC| Business
PORTLAND, Ore., May 08, 2018 -- Electro Scientific Industries, Inc. (NASDAQ:ESIO), an innovator of laser-based manufacturing solutions for the microtechnology industry, today announced results for its fiscal 2018 fourth...
Gladstone Land Announces First Quarter 2018 Results
May 08, 2018 20:06 pm UTC| Business
McLEAN, Va., May 08, 2018 -- Gladstone Land Corporation (Nasdaq:LAND) (“Gladstone Land” or the “Company”) today reported financial results for the first quarter ended March 31, 2018. A reconciliation of funds from...
Midland States Bancorp, Inc. Declares Quarterly Cash Dividend of $0.22 Per Share
May 08, 2018 20:06 pm UTC| Business
EFFINGHAM, Ill., May 08, 2018 -- Midland States Bancorp, Inc. (NASDAQ:MSBI) announced today that its Board of Directors declared a quarterly cash dividend of $0.22 per share. The dividend is payable on or about May 25,...
AGTC Announces Financial Results and Business Update for the Quarter Ended March 31, 2018
May 08, 2018 20:06 pm UTC| Business
GAINESVILLE, Fla. and CAMBRIDGE, Mass., May 08, 2018 -- Applied Genetic Technologies Corporation (Nasdaq:AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene...
Tabula Rasa HealthCare Announces First Quarter 2018 Operating Results
May 08, 2018 20:06 pm UTC| Business
MOORESTOWN, N.J., May 08, 2018 -- Tabula Rasa HealthCare, Inc. (“TRHC”) (NASDAQ:TRHC), a healthcare technology company advancing the field of medication safety, today announced its financial results for the first...
May 08, 2018 20:06 pm UTC| Business
FREMONT, Calif., May 08, 2018 -- Zosano Pharma Corporation (NASDAQ:ZSAN) (“Zosano” or the “Company”) a clinical-stage biopharmaceutical company focused on providing rapid systemic administration of therapeutics to...
Ovid Therapeutics Reports First Quarter 2018 Financial Results and Corporate Progress
May 08, 2018 20:06 pm UTC| Business
Data readouts for Ovid’s two lead programs expected in 2018: OV101 STARS trial for adults and adolescents with Angelman syndrome (AS) in third quarter and TAK-935/OV935 Phase 1b/2a trial for adults with rare developmental...
Trump Floats Greenland Framework, Bets Big on ‘Mission 500’ With India